Drugs / Quadrivalent split influenza virus vaccine
Quadrivalent split influenza virus vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05645900 Comparator | Feb → Oct 2023 | influenza | Ab&B Bio-tech Co., Ltd.JS | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quadrivalent split influenza virus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05645900 ↗ |
| Modality | Vaccine | “Biological: Quadrivalent split influenza virus vaccine” NCT05645900 ↗ |
| Route | Intramuscular | “by intramuscular injection” NCT05645900 ↗ |